Analyze Diet

Topic:Medication

The topic of medication in horses encompasses the study and application of pharmaceutical substances used to treat, manage, or prevent diseases and conditions in equine patients. This field involves understanding the pharmacokinetics and pharmacodynamics of various drugs, including their absorption, distribution, metabolism, and excretion in horses. Medications commonly administered to horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anthelmintics, and sedatives. The appropriate use of these medications is critical for ensuring therapeutic efficacy and minimizing adverse effects. Research in this area focuses on dosage optimization, drug interactions, resistance development, and withdrawal times to ensure both the health of the horse and compliance with regulatory standards. This page aggregates peer-reviewed studies and scholarly articles that explore the pharmacological aspects, clinical applications, and regulatory considerations of equine medications.
Risk of septic arthritis after intra-articular medication: a study of 16,624 injections in Thoroughbred racehorses.
Australian veterinary journal    June 21, 2013   Volume 91, Issue 7 268-273 doi: 10.1111/avj.12073
Steel CM, Pannirselvam RR, Anderson GA.The aims of this study were to determine the risk of septic arthritis after intra-articular medication (IAM) and to identify potential risk factors for this complication. Methods: A retrospective and prospective descriptive study of prevalence, and matched case-control study for risk factors. Results: Of 16,624 joints injected in 1103 horses at 6695 horse-visits, septic arthritis occurred as a complication in 13 joints (13 horses). The risk of septic arthritis following IAM was 7.8 cases per 10,000 injections or 1 case per 1279 injections. Veterinarian and type of corticosteroid were identifie...
Postcastration analgesia in ponies using buprenorphine hydrochloride.
The Veterinary record    June 4, 2013   Volume 172, Issue 24 635 doi: 10.1136/vr.101440
Love EJ, Taylor PM, Whay HR, Murrell J.Buprenorphine has recently obtained UK Marketing Authorisation for horses. The analgesic effects are long lasting, and have considerable potential for postoperative pain relief. This observer blinded, randomised study aimed to evaluate postsurgical analgesia in ponies premedicated with buprenorphine prior to castration under intravenous anaesthesia. Ponies received either 0.01 mg/kg bodyweight (BW) buprenorphine (group B) or an equivalent volume of 5 per cent glucose (group C) given intravenously before induction of anaesthesia. Pain was assessed and recorded using dynamic interactive visual a...
Shutting the stable door after the horse (on phenylbutazone) has bolted.
Veterinary journal (London, England : 1997)    May 23, 2013   Volume 196, Issue 3 273-274 doi: 10.1016/j.tvjl.2013.05.001
Higgins A.No abstract available
Pharmacokinetics of a peroral single dose of two long-acting formulations and an aqueous formulation of doxycycline hyclate in horses.
Acta veterinaria Scandinavica    March 8, 2013   Volume 55, Issue 1 21 doi: 10.1186/1751-0147-55-21
Zozaya H, Gutierrez L, Bernad MJ, Sumano H.Doxycyline (Dox) is a semisynthetic antibacterial drug with pharmacological advantages over its parent drug (tetracycline) in the treatment of various bacterial diseases in horses. Yet, at present a horse-customized pharmaceutical formulation is not available. Based on its pharmacokinetic/pharmacodynamic (PK/PD) ratio, Dox is considered a time-dependent antibacterial drug and ideally expected to achieve sustained plasma drug concentrations both at or slightly above the minimal inhibitory concentration (MIC) level for as long as possible between dosing intervals. Hence, the objective of this st...
Pharmacokinetics and safety of oral administration of meloxicam to foals.
Journal of veterinary internal medicine    February 20, 2013   Volume 27, Issue 2 300-307 doi: 10.1111/jvim.12045
Raidal SL, Edwards S, Pippia J, Boston R, Noble GK.The pharmacokinetics, efficacy, and safety of meloxicam have been evaluated in adult horses, but not foals. Physiologic differences between neonates and adults might alter drug pharmacokinetics and therapeutic index. Objective: The pharmacokinetics of meloxicam will be different in foals compared with adult horses, and foals could be at increased risk for adverse drug effects. Methods: Twenty lightbreed foals less than 6 weeks of age at commencement of the study. Methods: Single and repeated oral dose pharmacokinetics were determined for meloxicam (0.6 mg/kg) in 10 foals. The safety of the d...
Topics in equine anesthesia.
The Veterinary clinics of North America. Equine practice    February 9, 2013   Volume 29, Issue 1 ix-x doi: 10.1016/j.cveq.2013.01.001
Clark-Price SC.No abstract available
Inhaled anesthetics in horses.
The Veterinary clinics of North America. Equine practice    January 18, 2013   Volume 29, Issue 1 69-87 doi: 10.1016/j.cveq.2012.11.006
Brosnan RJ.Inhaled agents represent an important and useful class of drugs for equine anesthesia. This article reviews the ether-type anesthetics in contemporary use, their uptake and elimination, their mechanisms of action, and their desirable and undesirable effects in horses.
Pharmacokinetics and pharmacodynamic effects of tolazoline following intravenous administration to horses.
Veterinary journal (London, England : 1997)    January 12, 2013   Volume 196, Issue 3 504-509 doi: 10.1016/j.tvjl.2012.12.006
Casbeer HC, Knych HK.Tolazoline is an α2-adrenergic receptor antagonist, used in veterinary medicine to antagonize the central nervous system depressant and cardiovascular effects of α2 receptor agonists. The pharmacokinetics and pharmacodynamic effects of tolazoline when administered subsequent to detomidine in the horse were recently reported, although the reversal of the sedative and cardiovascular effects following detomidine may not be complete. The current study therefore investigated the pharmacokinetics and pharmacodynamic effects of tolazoline when administered as a sole agent. Nine healthy adult horses...
Total intravenous anesthesia in horses.
The Veterinary clinics of North America. Equine practice    December 23, 2012   Volume 29, Issue 1 123-129 doi: 10.1016/j.cveq.2012.11.008
Lerche P.Total intravenous anesthesia (TIVA) is the mainstay of short-term (up to 60 minutes) and field anesthesia in horses. This article discusses the pros and cons of TIVA, commonly used TIVA protocols, and their use, monitoring during, and recovery from, TIVA.
Robot-assisted surgery: searching for the pony.
Journal of endourology    December 13, 2012   Volume 26, Issue 12 1540-1541 doi: 10.1089/end.2012.1554
Menon M.No abstract available
Where does it hurt?
Equine veterinary journal    October 31, 2012   Volume 44, Issue 6 627-628 doi: 10.1111/j.2042-3306.2012.00661.x
Barr AR.No abstract available
Systemic or intrasynovial medication as singular or as combination treatment in horses with (peri-)synovial pain.
The Veterinary record    October 23, 2012   Volume 171, Issue 21 527 doi: 10.1136/vr.100811
Brommer H, Schipper P, Barneveld A, van Weeren PR.Records of lame horses (2004-2007) with (peri-)synovial pain of the metacarpophalangeal joint (MCPJ, n = 53), digital flexor tendon sheath (DFTS, n = 20), and distal interphalangeal joint (DIPJ, n = 31) were evaluated (n = 104). Cases were grouped according to the following treatments: (1) systemic administration of NSAIDs (n = 40); (2) intrasynovial administration of glucocorticosteroids (n = 30); (3) combination treatment (n = 34). Outcome was defined as successful when the owner reported that the horse had returned to its previous level of performance within a period of up to six months aft...
Pharmacokinetics of a continuous rate infusion of ceftiofur sodium in normal foals.
Journal of veterinary pharmacology and therapeutics    May 21, 2012   Volume 36, Issue 1 99-101 doi: 10.1111/j.1365-2885.2012.01403.x
Wearn JM, Davis JL, Hodgson DR, Raffetto JA, Crisman MV.No abstract available
Influence of exercise on the distribution of technetium Tc 99m medronate following intra-articular injection in horses.
American journal of veterinary research    March 1, 2012   Volume 73, Issue 3 418-425 doi: 10.2460/ajvr.73.3.418
Dulin JA, Drost WT, Phelps MA, Santschi EM, Menendez MI, Bertone AL.To determine the effects of exercise on the distribution and pharmacokinetics of technetium Tc 99m medronate ((99m)Tc-MDP) following intra-articular (IA) injection in horses. Methods: 5 horses. Methods: 1 antebrachiocarpal joint (ACJ)/horse was assigned to the exercised group (n = 5), and the contralateral ACJ was evaluated in the nonexercised group (5) after a minimum washout period of 7 days. Following IA injection of (99m)Tc-MDP (148 MBq), blood and scintigraphic images of the carpus were obtained at 5, 10, 15, 20, 25, 30, 45, 60, 90, 120, 240, 360, 480, 600, 720, and 1,440 minutes. Plasma ...
[Should “welfare” medication be allowed back?].
Tijdschrift voor diergeneeskunde    March 1, 2012   Volume 137, Issue 1 10-13 
van Weezel-Errens A.No abstract available
The use of phenytoin in two horses following conversion from atrial fibrillation.
New Zealand veterinary journal    February 15, 2012   Volume 60, Issue 3 210-212 doi: 10.1080/00480169.2011.643751
Dicken M, Gordon SJ, Mayhew IG.No abstract available
A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses.
Pharmaceutical research    February 4, 2012   Volume 29, Issue 6 1650-1657 doi: 10.1007/s11095-012-0686-8
Klier J, Fuchs S, May A, Schillinger U, Plank C, Winter G, Coester C, Gehlen H.In the recent years, nanotechnology has boosted the development of potential drug delivery systems and material engineering on nanoscale basis in order to increase drug specificity and reduce side effects. A potential delivery system for immunostimulating agents such as cytosine-phosphate-guanine-oligodeoxynucleotides (CpG-ODN) needs to be developed to maximize the efficacy of immunotherapy against hypersensitivity. In this study, an aerosol formulation of biodegradable, biocompatible and nontoxic gelatin nanoparticle-bound CpG-ODN 2216 was used to treat equine recurrent airway obstruction in ...
Ileal impaction in 245 horses: 1995-2007.
The Canadian veterinary journal = La revue veterinaire canadienne    January 3, 2012   Volume 52, Issue 7 759-763 
Fleming K, Mueller PO.The objective of this study was to identify parameters that would assist in determining the probability of a successful outcome with medical management versus surgical intervention in horses with ileal impaction. Medical records of 245 horses admitted for ileal impaction were reviewed and placed into 2 groups: medical (med) and surgical (sx) treatment. Persistence of abdominal pain, gastric reflux, frequency of analgesic administration, and 1-year survival were evaluated. There were no differences in signalment, abdominal pain, or heart rate among groups; however, significantly more sx horses ...
[Use of local anaesthetics in the horse. Pharmacological and legal aspects].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    December 6, 2011   Volume 39, Issue 2 117-123 
Kästner S.No abstract available
Pharmacokinetics of concurrently administered intravenous lidocaine and flunixin in healthy horses.
Journal of veterinary pharmacology and therapeutics    December 2, 2011   Volume 35, Issue 4 413-416 doi: 10.1111/j.1365-2885.2011.01356.x
Waxman SJ, KuKanich B, Milligan M, Beard WL, Davis EG.No abstract available
Horse racing eyes changes to stay relevant: new drug penalties, security, medication guidelines up for debate.
Journal of the American Veterinary Medical Association    November 24, 2011   Volume 239, Issue 9 1165-1167 
Larkin M.No abstract available
Treatment of equine sarcoid in seven Cape mountain zebra (Equus zebra zebra).
Journal of wildlife diseases    November 22, 2011   Volume 47, Issue 4 917-924 doi: 10.7589/0090-3558-47.4.917
Marais HJ, Page PC.Equine sarcoid has been diagnosed in endangered Cape mountain zebra (Equus zebra zebra) in at least two game reserves in South Africa, with prevalence as high as 53% in Bontebok National Park. Seven Cape mountain zebras with sarcoids were treated with either surgical excision, 5-fluorouracil, allogenous vaccine, or a combination of 5-fluorouracil and allogenous vaccine. One of the two sarcoids on one of the 5-fluorouracil-treated zebras was left untreated. The microscopic features of the tumors evaluated showed either all or most of the typical epidermal and dermal histologic features of equin...
Pharmacokinetic assessment of ketanserin in the horse.
Journal of veterinary pharmacology and therapeutics    November 18, 2011   Volume 35, Issue 5 472-477 doi: 10.1111/j.1365-2885.2011.01346.x
Aljuffali IA, Brainard BM, Moore JN, Kwon S, Allen D, Robertson TP, Arnold RD.The purpose of this study was to determine the pharmacokinetics (PK) of the 5-HT(2A) receptor antagonist ketanserin in healthy adult horses, and to develop a computational model that could be used to optimize dosing. Plasma concentrations of ketanserin were determined using liquid chromatography with mass spectrometry after single and multiple intravenous administration in the horse. A two-compartment linear pharmacokinetic model described the plasma concentration-time profile of ketanserin after single and multiple doses in healthy horses; the terminal half-life was 11.5 h; steady-state volum...
Validation of a liquid chromatography-tandem mass spectrometry method for quantification of glycopyrrolate in horse plasma.
Journal of analytical toxicology    November 15, 2011   Volume 35, Issue 9 656-664 doi: 10.1093/anatox/35.9.656
Rumpler MJ, Sams RA, Colahan P.A rapid, sensitive, and specific ultra-high-performance liquid chromatography with heated electrospray ionization-tandem mass spectrometry (UHPLC-HESI-MS-MS) method to detect and quantify glycopyrrolate in horse plasma has been developed and validated. We also determined glycopyrrolate in plasma after oral and intravenous administration of clinically relevant doses to Thoroughbred horses. Calibration was accomplished by weighted, linear regression analysis using a deuterated analogue of glycopyrrolate as internal standard (IS). Glycopyrrolate (GLY) and the IS (GLY-d(3)) were isolated from plas...
Macrocyclic lactones for parasite control in equids.
Current pharmaceutical biotechnology    November 2, 2011   Volume 13, Issue 6 1070-1077 doi: 10.2174/138920112800399310
Lyons ET, Tolliver SC.Macrocyclic lactones (MLs) revolutionized parasite control in horses and other animals. They are unique in that they are effective against arthropods and nematodes. The first of the widely used avermectins was ivermectin. In 1983, it was marketed for use in horses as an injectable formulation but was withdrawn in 1984 after about a year and half on the market because of adverse problems. It was replaced by a paste formulation and an oral/stomach tube liquid formulation. Ivermectin is highly active on bots, ascarids, large and small strongyles, pinworms, strongyloides, stomach worms, and some o...
Finding medicines for horses.
The Veterinary record    September 6, 2011   Volume 169, Issue 10 245-246 doi: 10.1136/vr.d5471
Price S, Spagnuolo-Weaver M.No abstract available
Treating navicular syndrome in equine patients.
Compendium (Yardley, PA)    September 2, 2011   Volume 33, Issue 1 E2 
Waguespack RW, Hanson RR.Navicular syndrome is a chronic, progressive condition affecting the navicular bone and bursa, deep digital flexor tendon (DDFT), and associated soft tissue structures composing the navicular apparatus. The treatment options for navicular syndrome are as varied as the proposed causes of the condition. The severity of clinical signs, intended use and workload of the horse, and owner compliance with therapy are important considerations in developing a treatment plan. Nonsurgical treatment of navicular syndrome consists of rest, hoof balance and corrective trimming/shoeing, and medical therapy, i...
Persistent penile erection (priapism) after acepromazine premedication in a gelding.
Veterinary anaesthesia and analgesia    August 13, 2011   Volume 38, Issue 5 523-525 doi: 10.1111/j.1467-2995.2011.00641.x
Taylor AH, Bolt DM.No abstract available
Cardiovascular effects of N-butylscopolammonium bromide and xylazine in horses.
Equine veterinary journal. Supplement    August 4, 2011   Issue 39 117-122 doi: 10.1111/j.2042-3306.2011.00400.x
Morton AJ, Varney CR, Ekiri AB, Grosche A.N-butylscopolammonium bromide (NBB) and xylazine are commonly used medications for the treatment of spasmodic colic and other forms of abdominal pain in horses. Both NBB and xylazine exert significant effects on the cardiovascular system and other vital systems of horses. Objective: To evaluate the effects of i.v. administration of NBB, xylazine, and the combination of NBB and xylazine on heart rate, other commonly measured physiological parameters, cardiac rhythm and blood pressure. Methods: Six mature horses of mixed breed were used. In a random cross-over design, each horse was given 0.3 mg...
Effects of intrarectally administered omeprazole paste on gastric fluid pH in healthy adult horses.
The Veterinary record    July 5, 2011   Volume 169, Issue 5 126 doi: 10.1136/vr.d3909
Rand C, Stanley SD, Pusterla N.No abstract available
1 5 6 7 8 9 36